{"id":165824,"name":"SAGE THERAPEUTICS, INC.","slug":"sage-therapeutics-inc","state":"MA","country":"United States of America","description":"Pharmaceutical manufacturing","totalSpending":1120000,"filings":24,"yearlySpending":[{"year":2019,"income":120000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"},{"code":"HOM","display":"Homeland Security"}],"firms":["AVENUE SOLUTIONS"],"lobbyists":["AMY TEJRAL","TRACY SPICER","ELIZABETH BARNETT","JORDAN LACROSSE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Disease Control & Prevention (CDC)","Health & Human Services, Dept of (HHS)","White House Office","Office of the Vice President of the United States","Substance Abuse & Mental Health Services Administration (SAMHSA)"],"sampleDescriptions":["Issues related to mental health, postpartum depression, Medicaid, value of prescription drugs","Issues related to mental health, postpartum depression, Medicaid, value of prescription drugs","Issues related to mental health, postpartum depression, Medicaid, value of prescription drugs","Education and awareness of mental health issues, particularly post-partum depression","Education and awareness of mental health issues, particularly postpartum depression"]}